THE EFFECT OF HISTONE DEACETYLASE INHIBITOR ENTINOSTAT ON INVASION AND MIGRATION OF LUNG CANCER

被引：0
|
作者：
Zeng, Yunlong [1 ]
Xiong, Qingqing [2 ]
Wang, Tao [3 ]
机构：
[1] Jiangxi Chest Hosp, Dept Pharm, Nanchang 330006, Jiangxi, Peoples R China
[2] Jiangxi Chest Hosp, Dept Neurol, Nanchang 330006, Jiangxi, Peoples R China
[3] Jiangxi Chest Hosp, Dept Surg, Nanchang 330006, Jiangxi, Peoples R China
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2023年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
53
引用
收藏
页码：26 / 28
页数：3
相关论文
共 50 条
  • [41] Histone deacetylase 1 mRNA expression in lung cancer
    Sasaki, H
    Moriyama, S
    Nakashima, Y
    Kobayashi, Y
    Kiriyama, M
    Fukai, I
    Yamakawa, Y
    Fujii, Y
    LUNG CANCER, 2004, 46 (02) : 171 - 178
  • [42] Effect of histone deacetylase inhibitor in combination with gemcitabine on pancreas cancer and cholanglocarcinoma cell line
    Iwahashi, S.
    Shimada, M.
    Utsunomiya, T.
    Morine, Y.
    Imura, S.
    Ikemoto, T.
    Hanaoka, J.
    Saito, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] In vivo enrichment of cancer stem cells in histone deacetylase inhibitor resistant xenograft of lung cancer in mouse model
    Kuo, Wei-Ying
    Hwu, Luen
    Wu, Chun-Yi
    Wang, Hsin-Ell
    Liu, Ren-Shyan
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [44] Identification of histone deacetylase 10 as a repressor of cancer cell migration
    Liu, Ting-Ann
    Nwafor, Ashley
    Kumar, Rajendra
    Sena, Laura
    Steimbach, Raphael R.
    Miller, Aubry K.
    Casero, Robert A.
    Stewart, Tracy Murray
    CANCER RESEARCH, 2024, 84 (07)
  • [45] Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells
    Wightman, Fiona
    Lu, Hao K.
    Solomon, Ajantha E.
    Saleh, Suha
    Harman, Andrew N.
    Cunningham, Anthony L.
    Gray, Lachlan
    Churchill, Melissa
    Cameron, Paul U.
    Dear, Anthony E.
    Lewin, Sharon R.
    AIDS, 2013, 27 (18) : 2853 - 2862
  • [46] Topical histone deacetylase 1 inhibitor Entinostat ameliorates psoriasiform dermatitis through suppression of IL-17A response
    Jiang, Yanyun
    Lu, Siyao
    Lai, Yuhsien
    Wang, Liangchun
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2023, 110 (03) : 89 - 98
  • [47] Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure
    Johanna K. Freundt
    Gerrit Frommeyer
    Tilmann Spieker
    Fabian Wötzel
    Jochen Schulze Grotthoff
    Jörg Stypmann
    Georg Hempel
    Michael Schäfers
    Andreas H. Jacobs
    Lars Eckardt
    Philipp S. Lange
    BMC Pharmacology and Toxicology, 20
  • [48] The Histone Deacetylase Inhibitor, MS-275 (Entinostat), Downregulates c-FLIP, Sensitizes Osteosarcoma Cells to FasL, and Induces the Regression of Osteosarcoma Lung Metastases
    Rao-Bindal, Krithi
    Koshkina, Nadezhda V.
    Stewart, John
    Kleinerman, Eugenie S.
    CURRENT CANCER DRUG TARGETS, 2013, 13 (04) : 411 - 422
  • [49] Hybrid Histone Deacetylase Inhibitor: An Effective Strategy for Cancer Therapy
    Wu, Jiyong
    Nie, Jing
    Luan, Yepeng
    Ding, Yanjiao
    CURRENT MEDICINAL CHEMISTRY, 2023, 30 (20) : 2267 - 2311
  • [50] Entinostat, a histone deacetylase inhibitor, increases the population of IL-10+ regulatory B cells to suppress contact hypersensitivity
    Min, Keun Young
    Lee, Min Bum
    Hong, Seong Hwi
    Lee, Dajeong
    Jo, Min Geun
    Lee, Ji Eon
    Choi, Min Yeong
    You, Jueng Soo
    Kim, Young Mi
    Park, Yeong Min
    Kim, Hyuk Soon
    Choi, Wahn Soo
    BMB REPORTS, 2021, 54 (10) : 534 - 539
12345